ACE2 and cardiovascular disorder: The use of ACEI or ARB likely promotes feedback upregulation of ACE2 expression in hypertension, although animal studies have found either no effect or even downregulation of ACE2 levels in the context of cardiovascular disease with ACEI/ARB therapy [27, 35-37].